Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose Response Curve: Conventional Versus Nonmonotonic01:21

Dose Response Curve: Conventional Versus Nonmonotonic

The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Minimum noninferiority dose for phase I clinical trials with immunotherapy.

Biometrics·2026
Same author

Patient Retreat in Dose Escalation for Phase I Clinical Trials With Rare Diseases.

Statistics in medicine·2026
Same author

Wasserstein GAN-based estimation for conditional distribution function with current status data.

Lifetime data analysis·2026
Same author

Learning from the omicron BA.4/5 dominance: Strategies for future vaccination preparedness.

Vaccine·2025
Same author

SIB-MIL: Sparsity-Induced Bayesian Neural Network for Robust Multiple Instance Learning on Whole Slide Image Analysis.

IEEE transactions on medical imaging·2025
Same author

Decision Tables for Calibration-Free Odds Design in Phase I Clinical Trials.

JCO precision oncology·2025

Related Experiment Video

Updated: Jun 1, 2026

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)
13:54

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)

Published on: August 18, 2023

Dose-response curve estimation: a semiparametric mixture approach.

Ying Yuan1, Guosheng Yin

  • 1Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA. yyuan@mdanderson.org

Biometrics
|June 2, 2011
PubMed
Summary

This study introduces a semiparametric dose-response curve estimation method. It balances parametric efficiency with nonparametric robustness, offering a flexible and consistent approach for modeling relationships.

More Related Videos

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays
06:13

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Published on: February 21, 2020

Related Experiment Videos

Last Updated: Jun 1, 2026

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)
13:54

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)

Published on: August 18, 2023

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays
06:13

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Published on: February 21, 2020

Area of Science:

  • Biostatistics
  • Statistical Modeling
  • Pharmacometrics

Background:

  • Parametric models offer efficiency in dose-response curve estimation but risk misspecification.
  • Nonparametric methods provide robustness but often lack efficiency.
  • A need exists for methods combining the strengths of both approaches.

Purpose of the Study:

  • To propose a novel semiparametric approach for dose-response curve estimation.
  • To develop an estimator that achieves efficiency when parametric assumptions hold and consistency when they are violated.
  • To introduce an adaptive weighting scheme for improved local model fitting.

Main Methods:

  • A semiparametric estimator is proposed as a weighted average of parametric and nonparametric estimates.
  • Weights are assigned based on the goodness-of-fit of each model.
  • An adaptive weighting scheme is developed to adjust weights locally.

Main Results:

  • The semiparametric estimator demonstrates efficiency comparable to parametric methods when models are correctly specified.
  • The estimator maintains consistency, similar to nonparametric methods, when parametric models are misspecified.
  • Simulation studies and real-world examples validate the proposed method's performance.

Conclusions:

  • The proposed semiparametric method offers a robust and efficient alternative for dose-response curve estimation.
  • This approach mitigates the risks associated with purely parametric or nonparametric modeling.
  • The adaptive weighting scheme enhances the flexibility and accuracy of the estimation.